Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
1.220
+0.040 (3.39%)
At close: Mar 20, 2026, 4:00 PM EDT
1.190
-0.030 (-2.46%)
After-hours: Mar 20, 2026, 7:10 PM EDT

Phio Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-8.7-7.15-10.83-11.48-13.29
Depreciation & Amortization
000.060.070.08
Stock-Based Compensation
0.480.150.30.410.48
Other Adjustments
-0.030.250.12-0.12
Changes in Accounts Payable
0.18-0.4-0.120.5-0.45
Changes in Accrued Expenses
0.14-0.18-0.08-1.641.31
Changes in Other Operating Activities
-0.090.45-0.33-0.120.13
Operating Cash Flow
-7.98-7.11-10.75-12.13-11.86
Capital Expenditures
-0.01-0-0.01-0.12-0.05
Sale of Property, Plant & Equipment
-0.01---
Investing Cash Flow
-0.010.01-0.01-0.12-0.05
Issuance of Common Stock
23.6747.45-21.72
Repurchase of Common Stock
-0.03-0.01-0.04-0.03-0
Net Common Stock Issued (Repurchased)
23.6447.42-0.0321.72
Issuance of Preferred Stock
---0-
Repurchase of Preferred Stock
---0--
Net Preferred Stock Issued (Repurchased)
---00-
Financing Cash Flow
23.6447.41-0.0321.72
Net Cash Flow
15.65-3.11-3.34-12.289.81
Free Cash Flow
-7.99-7.11-10.75-12.25-11.91
Free Cash Flow Per Share
-1.34-9.03-46.45-97.00-100.24
Levered Free Cash Flow
-8.47-7.29-11.31-12.79-12.27
Unlevered Free Cash Flow
-8.99-7.52-11.31-12.77-12.5
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q